Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Alexander

Showing results (941-950 of 1,212) with videos related to

Pageof 122
Sort By:
European Heart Journal|October 26, 2017
A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk scoreZiad Hijazi, Jonas Oldgren, Johan Lindbäck, et al.
Veterinary World|August 22, 2022
Seroprevalence and risk factors associated with bovine herpesvirus 1 in dairy herds of ColombiaAura Daniela Ortiz-González, H Alexander Lopez Buitrago, Diana María Bulla-Castañeda, et al.
American Heart Journal|June 17, 2004
Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the Assessment of the Safety of a New Thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarctionPeter R Sinnaeve, John H Alexander, Kris Bogaerts, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 25, 2019
The Efficacy and Safety of Vertebral Augmentation: A Second ASBMR Task Force ReportPeter R Ebeling, Kristina Akesson, Douglas C Bauer, et al.
American Heart Journal|September 11, 2013
Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trialDavid A Garcia, Lars Wallentin, Renato D Lopes, et al.
Lancet (London, England)|April 9, 2016
The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation studyZiad Hijazi, Jonas Oldgren, Johan Lindbäck, et al.
British Journal of Pharmacology|November 12, 2019
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Catalytic receptorsStephen P H Alexander, Doriano Fabbro, Eamonn Kelly, et al.
JAMA Cardiology|July 28, 2016
Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical TrialJohn H Alexander, Ulrika Andersson, Renato D Lopes, et al.
The American Journal of Medicine|December 6, 2003
Prognostic importance of new small Q waves following non-ST-elevation acute coronary syndromesJohn H Alexander, Robert A Harrington, Manju Bhapkar, et al.
JAMA Cardiology|January 19, 2017
The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A ReviewPaul L Hess, Jeff S Healey, Christopher B Granger, et al.
Pageof 122

Showing results (941-950 of 1,212) with videos related to

Sort By:
Pageof 122
European Heart Journal|October 26, 2017
A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk scoreZiad Hijazi, Jonas Oldgren, Johan Lindbäck, et al.
Veterinary World|August 22, 2022
Seroprevalence and risk factors associated with bovine herpesvirus 1 in dairy herds of ColombiaAura Daniela Ortiz-González, H Alexander Lopez Buitrago, Diana María Bulla-Castañeda, et al.
American Heart Journal|June 17, 2004
Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the Assessment of the Safety of a New Thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarctionPeter R Sinnaeve, John H Alexander, Kris Bogaerts, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 25, 2019
The Efficacy and Safety of Vertebral Augmentation: A Second ASBMR Task Force ReportPeter R Ebeling, Kristina Akesson, Douglas C Bauer, et al.
American Heart Journal|September 11, 2013
Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trialDavid A Garcia, Lars Wallentin, Renato D Lopes, et al.
Lancet (London, England)|April 9, 2016
The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation studyZiad Hijazi, Jonas Oldgren, Johan Lindbäck, et al.
British Journal of Pharmacology|November 12, 2019
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Catalytic receptorsStephen P H Alexander, Doriano Fabbro, Eamonn Kelly, et al.
JAMA Cardiology|July 28, 2016
Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical TrialJohn H Alexander, Ulrika Andersson, Renato D Lopes, et al.
The American Journal of Medicine|December 6, 2003
Prognostic importance of new small Q waves following non-ST-elevation acute coronary syndromesJohn H Alexander, Robert A Harrington, Manju Bhapkar, et al.
JAMA Cardiology|January 19, 2017
The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A ReviewPaul L Hess, Jeff S Healey, Christopher B Granger, et al.
Pageof 122